[Voluntary abortion: new perspectives in local anesthesia].
New perspectives have been envisioned for the TOP instrumental technique, through the utilization of pharmacologic products, whose property is to dilatate the cervix. Misoprostol or mifepristone, when administrated to a patient a few hours before a TOP by uterine suction curettage, enables a dilatation of the cervix in such a way that it allows the surgically induced abortion to be carried out with local anesthesia, under optimal comfort conditions for the patients as well as for the operator.
Lefebvre
P
P
Centre de planification et d'interruption volontaire de grossesse, Hôpital de la Fraternité, Roubaix.
Monniez
N
N
Norel
G
G
Prévost
D
D
Scharfman
W
W
D000020:Abortifacient Agents, Nonsteroidal; D000021:Abortifacient Agents, Steroidal; D000028:Abortion, Induced / Q000379:methods*; D000772:Anesthesia, Local / Q000379:methods* / Q000639:trends*; D006801:Humans; D015735:Mifepristone; D016595:Misoprostol
D000020:Abortifacient Agents, Nonsteroidal; D000021:Abortifacient Agents, Steroidal; D016595:Misoprostol; D015735:Mifepristone
Interruption volontaire de grossesse: nouvelles perspectives de l'anesthésie locale.